Suppr超能文献

透明质酸微针在胰岛素智能递送系统治疗糖尿病中的应用

[Application of hyaluronic acid microneedles in insulin intelligent delivery system for the treatment of diabetes].

作者信息

Xiao Yongcheng, Wang Xiaobin, Xie Deming

机构信息

College of Life Science and Technology, Jinan University, Guangzhou 510630, Guangdong, China.

Guangzhou Quality Supervision and Testing Institute, Guangzhou 511447, Guangdong, China.

出版信息

Sheng Wu Gong Cheng Xue Bao. 2022 Sep 25;38(9):3433-3442. doi: 10.13345/j.cjb.220129.

Abstract

In this study, insulin (insulin, INS)/CaPO complex and glucose oxidase (glucose oxidase, GOx)/Cu(PO) complex were prepared by coprecipitation method. The mineralized insulin (mineralized insulin, m-INS) showed irregular crystalline clusters, and the mineralized glucose oxidase (m-GOx) showed flower spherical morphology, with a diameter of about 1-2 μm. simulated release experiment showed that m-INS released INS as the pH value of the medium decreased. When the pH value was 4.5, the release amount reached 96.68%. The enzyme activity detection experiment showed that the enzyme activity stability of m-GOx was higher than that of free GOx. It still maintained high activity after 10 days at room temperature, while the activity of GOx was less than 60%. The glucose solution was prepared to simulate the state of normal blood glucose (5.6 mmol/L) and hyperglycemia (22.2 mmol/L). When m-INS and m-GOx were added to the glucose solution, the release amount of INS showed a significant glucose concentration dependence. The higher the glucose concentration, the greater the release amount and release rate of INS. Finally, m-INS, m-GOx and hyaluronic acid (HA) solution were mixed to prepare HA microneedle arrays loaded with m-INS and m-GOx. Type 1 diabetes mice were constructed to evaluate the effect of drug-loaded HA microarray on blood glucose control in diabetic rats. The results show that the HA microneedles loaded with m-INS/m-GOx could deliver drugs effectively. The average blood glucose concentration in diabetic rats dropped to about 7 mmol/L within 1 h, normal blood glucose concentration could be maintained for 10 h, and the overall blood glucose concentration was lower than the level before administration for 36 hours. Compared with HA microneedles loaded with INS only, m-ins microneedles showed better glucose tolerance, longer-lasting glucose control effect and less risk of hypoglycemia. Compared with other sustained-release systems, the preparation process of the core components in this study is simple, efficient, safe and effective, and has great commercial potential.

摘要

在本研究中,通过共沉淀法制备了胰岛素(insulin,INS)/磷酸钙(CaPO)复合物和葡萄糖氧化酶(glucose oxidase,GOx)/磷酸铜(Cu(PO))复合物。矿化胰岛素(mineralized insulin,m-INS)呈现不规则晶体簇,矿化葡萄糖氧化酶(m-GOx)呈现花球状形态,直径约为1-2μm。模拟释放实验表明,随着培养基pH值降低,m-INS释放出INS。当pH值为4.5时,释放量达到96.68%。酶活性检测实验表明,m-GOx的酶活性稳定性高于游离GOx。在室温下放置10天后,它仍保持高活性,而GOx的活性则低于60%。制备葡萄糖溶液以模拟正常血糖(5.6 mmol/L)和高血糖(22.2 mmol/L)状态。当将m-INS和m-GOx添加到葡萄糖溶液中时,INS的释放量呈现出显著的葡萄糖浓度依赖性。葡萄糖浓度越高,INS的释放量和释放速率越大。最后,将m-INS、m-GOx与透明质酸(HA)溶液混合,制备负载m-INS和m-GOx的HA微针阵列。构建1型糖尿病小鼠以评估载药HA微阵列对糖尿病大鼠血糖控制的效果。结果表明,负载m-INS/m-GOx的HA微针能够有效递送药物。糖尿病大鼠的平均血糖浓度在1小时内降至约7 mmol/L,可维持正常血糖浓度10小时,并且在36小时内总体血糖浓度低于给药前水平。与仅负载INS的HA微针相比,m-ins微针表现出更好的葡萄糖耐受性、更持久的血糖控制效果和更低的低血糖风险。与其他缓释系统相比,本研究中核心成分的制备过程简单、高效、安全且有效,具有巨大的商业潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验